Boyer David W. — SEC Form 4 filings
SEC reporting owner CIK 1909817. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-02 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 10 filings — 18,750 shares, $2,548,823 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: sale of 3,888 shares @ $156.64 ($609,023) in NEUROCRINE BIOSCIENCES INC, filed 2026-05-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Corp. Affairs Officer | 12 | — | 16 legs · 18,750 sh · $2,548,823 | 30 |
Form 4 filings — Boyer David W.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 3,587 @ $0 · Tax withholding (F): 1,936 @ $156.22 · Sale (S): 826 @ $157.45 | EDGAR |
| 2026-05-28 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 3,888 @ $156.64 | EDGAR |
| 2026-02-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,600 @ $0 · Tax withholding (F): 864 @ $123.10 · Option exercise (M): 1,541 @ $0 · Tax withholding (F): 832 @ $124.12 · Option exercise (M): 1,811 @ $0 · Tax withholding (F): 978 @ $124.12 · +7 more | EDGAR |
| 2026-02-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,096 @ $0 · Tax withholding (F): 1,189 @ $136.06 · Option exercise (M): 2,096 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,811 @ $0 · Sale (S): 955 @ $116.79 · Option exercise (M): 1,541 @ $0 · Sale (S): 830 @ $116.69 · Grant/award (A): 34,153 (derivative) @ $0 · Grant/award (A): 6,401 (derivative) @ $0 · +2 more | EDGAR |
| 2025-02-12 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,329 @ $0 · Sale (S): 700 @ $118.31 · Option exercise (M): 1,329 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,096 @ $0 · Sale (S): 1,104 @ $152.94 · Option exercise (M): 2,096 (derivative) @ $0 | EDGAR |
| 2024-10-07 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,295 @ $113.66 | EDGAR |
| 2024-09-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 3,461 @ $121.88 | EDGAR |
| 2024-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 955 @ $133.10 · Sale (S): 856 @ $133.05 · Grant/award (A): 30,977 (derivative) @ $0 · Grant/award (A): 6,165 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 240 @ $141.96 · Sale (S): 216 @ $141.96 · Sale (S): 700 @ $134.19 · Sale (S): 628 @ $136.78 | EDGAR |
| 2024-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,104 @ $140.87 · Sale (S): 992 @ $140.72 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1909817 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →